Brief: Medmix H1 Adjusted EBITDA CHF 43.5 Million
BRIEF-Medmix H1 Adjusted EBITDA CHF 43.5 Million Jul 23 (Reuters) - Medmix H1 adjusted EBITDA margin 20.3%.
- H1 free cash flow CHF 12 million
- outlook FY adjusted EBITDA margin 20%
BRIEF-Medmix H1 Adjusted EBITDA CHF 43.5 Million Jul 23 (Reuters) - Medmix H1 adjusted EBITDA margin 20.3%.